Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles: 2017-2025
Historic Goodwill & Intangibles for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to $1.2 billion.
- Amneal Pharmaceuticals' Goodwill & Intangibles fell 14.12% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 14.12%. This contributed to the annual value of $1.3 billion for FY2024, which is 10.69% down from last year.
- According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Goodwill & Intangibles is $1.2 billion, which was down 5.06% from $1.2 billion recorded in Q2 2025.
- Amneal Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $1.8 billion for Q2 2021, and its period low was $1.2 billion during Q3 2025.
- Over the past 3 years, Amneal Pharmaceuticals' median Goodwill & Intangibles value was $1.4 billion (recorded in 2024), while the average stood at $1.4 billion.
- In the last 5 years, Amneal Pharmaceuticals' Goodwill & Intangibles declined by 19.83% in 2021 and then climbed by 1.51% in 2022.
- Over the past 5 years, Amneal Pharmaceuticals' Goodwill & Intangibles (Quarterly) stood at $1.8 billion in 2021, then declined by 3.69% to $1.7 billion in 2022, then decreased by 12.15% to $1.5 billion in 2023, then fell by 10.69% to $1.3 billion in 2024, then decreased by 14.12% to $1.2 billion in 2025.
- Its Goodwill & Intangibles stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.3 billion for Q1 2025.